PATENT CLAIM ANALYSIS

Application Number: 16029373
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-10
Patent Classification: ["424", "133100"]

Abstract:
The present invention provides methods and systems to accurately detect and measure levels of endogenous antibodies, for examples endogenous IgA, to particular antigens in a biological sample from a companion animal, which is useful to diagnose inflammatory conditions, including bowel disease (IBD), gastrointestinal infections, and food sensitivities in companion animals, e.g., dogs or cats, and to distinguish among such gastrointestinal disorders. Such methods and systems identify whether a sample from the patient is associated with an inflammatory condition, infection, and/or food sensitivity condition, by using non-invasive means, thus conveniently providing information useful for guiding treatment decisions.

Claim (Index 27):
The isolated peptide of claim  22 , wherein the peptide is bound to a solid substrate.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 1.46753
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15592104', '10449857', '12352578', '13190369', '12352579']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7439850000930214
- 35 USC 102 Novelty (BERT): 0.5560914224562966
- Combined Prediction Score: 0.7251956423293489
- Mean Citation Score: 287.216198
- Max Citation Score: 510.6298
- Similarity Product: 272.8049248765826

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test